Outcomes and risk factors of SARS-CoV-2 omicron variant in B-cell lymphoma patients following CD19 targeted CAR-T therapy.

Xibin XiaoPanpan ChenYadi ZhongXiu LuoYao LiuYing LuXueli JinWenbin QianWeidong HanAibin LiangHui Liu

Published in: Cancer medicine (2023)

Through this study, we conclude that the outcome for B-cell lymphoma patients following CD19 targeted CAR-T therapy when facing omicron infection was improved, but aggressive precautionary measures were particularly crucial for patients with high risk factors.

Keyphrases

risk factors
end stage renal disease
sars cov
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
diffuse large b cell lymphoma
metabolic syndrome
mesenchymal stem cells
patient reported outcomes
bone marrow
adipose tissue
skeletal muscle
glycemic control